Effect of 56 days of treatment (T56) on immunological parameters
| Fluticasone (n=11) | Placebo (n=12) | p value6-151 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Median | Range | Median | Range | ||||||
| T cells | 0.7 | 0.36–1.04 | 1.3 | 0.48–2.1 | 0.048 | ||||
| Primed T cells | 0.64 | 0.39–1.69 | 1.2 | 0.44–2.19 | 0.015 | ||||
| CD4:CD8 ratios | 0.63 | 0.33–1.36 | 0.88 | 0.07–2.31 | 0.3 | ||||
| CD68+ cells | 0.83 | 0.06–1.27 | 0.99 | 0.24–1.68 | 0.1 | ||||
| D1+MQ | 0.65 | 0.15–4.02 | 1.0 | 0.43–1.27 | 0.49 | ||||
| D7+MQ | 1.01 | 0.71–2.23 | 1.06 | 0.73–1.45 | 0.8 | ||||
| D1+/D7+MQ | 1.17 | 0.58–2.67 | 1.25 | 0.36–2.5 | 0.83 | ||||
| Eosinophils | 0.45 | 0.02–2.02 | 1.06 | 0.02–38 | 0.03 | ||||
| Activated eosinophils | 0.195 | 0.03–1.34 | 1.22 | 0.69–28 | 0.0017 | ||||
All figures are ratios reflecting T56/T0 data for each parameter.
↵6-151 Mann-Whitney test for non-parametric data.